AHCO

SEC source: 0000899243-22-009973 · doc4.xml · derivative · entry 4

SkyKnight Aero Holdings, LLC · CIK 0001793034 · Director

SkyKnight Capital, L.P. · CIK 0001842707 · Director

SkyKnight Capital Management, LLC · CIK 0001842708 · Director

SkyKnight Capital Fund II, L.P. · CIK 0001748212 · Director

SkyKnight Capital II GP, LLC · CIK 0001842706 · Director

Ebbel Matthew · CIK 0001842704 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By SkyKnight Capital Fund II, L.P.

Disclosed balance after: 0

Underlying: Class A Common Stock · 1,171,045 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings") and SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date.

F1 · kind: On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings") and SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date.

F1 · derivative.exercise_date: On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings") and SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date.

F1 · derivative.expiration_date: On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings") and SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date.

F3 · ownership.nature: Shares held by SkyKnight Fund II. SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

SEC source: 0000899243-22-009973 · doc4.xml · derivative · entry 3

SkyKnight Aero Holdings, LLC · CIK 0001793034 · Director

SkyKnight Capital, L.P. · CIK 0001842707 · Director

SkyKnight Capital Management, LLC · CIK 0001842708 · Director

SkyKnight Capital Fund II, L.P. · CIK 0001748212 · Director

SkyKnight Capital II GP, LLC · CIK 0001842706 · Director

Ebbel Matthew · CIK 0001842704 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 2,732,440 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings") and SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date.

F1 · kind: On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings") and SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date.

F1 · derivative.exercise_date: On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings") and SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date.

F1 · derivative.expiration_date: On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings") and SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date.

F2 · ownership.direct: Shares held by SkyKnight Aero Holdings. SkyKnight Capital, L.P. ("SkyKnight Capital") is the manager of SkyKnight Aero Holdings. SkyKnight Capital Management, LLC ("SkyKnight Capital Management") is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

SEC source: 0000899243-22-009973 · doc4.xml · nonDerivative · entry 2

SkyKnight Aero Holdings, LLC · CIK 0001793034 · Director

SkyKnight Capital, L.P. · CIK 0001842707 · Director

SkyKnight Capital Management, LLC · CIK 0001842708 · Director

SkyKnight Capital Fund II, L.P. · CIK 0001748212 · Director

SkyKnight Capital II GP, LLC · CIK 0001842706 · Director

Ebbel Matthew · CIK 0001842704 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By SkyKnight Capital Fund II, L.P.

Disclosed balance after: 2,426,919

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings") and SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date.

F1 · price: On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings") and SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date.

F3 · ownership.nature: Shares held by SkyKnight Fund II. SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

SEC source: 0000899243-22-009973 · doc4.xml · nonDerivative · entry 1

SkyKnight Aero Holdings, LLC · CIK 0001793034 · Director

SkyKnight Capital, L.P. · CIK 0001842707 · Director

SkyKnight Capital Management, LLC · CIK 0001842708 · Director

SkyKnight Capital Fund II, L.P. · CIK 0001748212 · Director

SkyKnight Capital II GP, LLC · CIK 0001842706 · Director

Ebbel Matthew · CIK 0001842704 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,662,814

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings") and SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date.

F1 · price: On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings") and SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date.

F2 · ownership.direct: Shares held by SkyKnight Aero Holdings. SkyKnight Capital, L.P. ("SkyKnight Capital") is the manager of SkyKnight Aero Holdings. SkyKnight Capital Management, LLC ("SkyKnight Capital Management") is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

SEC source: 0001104659-21-039162 · tm214849-20_4seq1.xml · nonDerivative · entry 2

Weaver Susan T · CIK 0001687804 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,064

SEC source: 0001104659-21-039162 · tm214849-20_4seq1.xml · nonDerivative · entry 1

Weaver Susan T · CIK 0001687804 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,459

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.03 to $38.043, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).

SEC source: 0001104659-21-038370 · tm214849d19_4seq1.xml · nonDerivative · entry 1

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,009

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $37.77 to $38.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).

SEC source: 0001104659-21-154716 · tm2136543-1_4aseq1.xml · nonDerivative · entry 1

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 7,000

F1 · shares: This amendment is being filed to include a purchase of shares of common stock of the issuer by the Dale B. Wolf Generation Skipping Trust (the "GST"), which was omitted inadvertently from the original filing.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $37.86 to $38.02, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).

F3 · ownership.nature: Securities held directly by the GST. The reporting person is the investment manager of the GST.

SEC source: 0001104659-21-037116 · tm214849-18_4seq1.xml · nonDerivative · entry 1

Rietkerk Shaw · CIK 0001792695 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,053

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.89 to $37.70, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).

SEC source: 0001567619-21-002151 · doc1.xml · derivative · entry 3

GRIGGS STEPHEN P · CIK 0001275762 · Director · Co-Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,090

Underlying: Class A Common Stock · 90,090 shares

Expires 2026-01-28

F3 · derivative.exercise_date: Options vest in three equal annual installments, beginning on January 28, 2022.

SEC source: 0001567619-21-002151 · doc1.xml · derivative · entry 2

GRIGGS STEPHEN P · CIK 0001275762 · Director · Co-Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,700

Underlying: Class A Common Stock · 77,700 shares

Expires 2026-01-28

F2 · derivative.exercise_date: Options vest in three equal annual installments, beginning on January 28, 2022.

SEC source: 0001567619-21-002151 · doc1.xml · derivative · entry 1

GRIGGS STEPHEN P · CIK 0001275762 · Director · Co-Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,600

Underlying: Class A Common Stock · 66,600 shares

Expires 2026-01-28

F1 · derivative.exercise_date: Options vest in three equal annual installments, beginning on January 28, 2022.

SEC source: 0001104659-21-010439 · tm214849-6_4seq1.xml · nonDerivative · entry 1

Parnes Josh · CIK 0001792687 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 208,528

F1 · price: On January 29, 2021, the issuer repurchased 19,597 shares of restricted Class A Common Stock from the reporting person.

SEC source: 0001104659-21-010441 · tm214849-3_4seq1.xml · derivative · entry 3

JOYCE CHRISTOPHER J · CIK 0001032563 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,667

Underlying: Class A Common Stock · 166,667 shares

Expires 2029-12-19

F2 · shares: On December 19, 2019, the reporting person was granted an option to purchase 500,000 shares of Class A Common Stock of the issuer. The option vests in three equal annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2020, 2021 and 2022. The performance criteria for 2020 were met, resulting in vesting of the option as to 166,667 shares.

F2 · derivative.exercise_date: On December 19, 2019, the reporting person was granted an option to purchase 500,000 shares of Class A Common Stock of the issuer. The option vests in three equal annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2020, 2021 and 2022. The performance criteria for 2020 were met, resulting in vesting of the option as to 166,667 shares.

SEC source: 0001104659-21-010441 · tm214849-3_4seq1.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,096

SEC source: 0001104659-21-010426 · tm214849-5_4seq1.xml · nonDerivative · entry 1

Mullen Frank · CIK 0001688412 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,739

SEC source: 0001104659-21-010444 · tm214849-7_4seq1.xml · derivative · entry 2

Rietkerk Shaw · CIK 0001792695 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,444

Underlying: Class A Common Stock · 69,444 shares

Expires not disclosed

F2 · derivative.exercise_price: On December 19, 2019, the reporting person was granted an option to purchase 208,333 shares of Class A Common Stock of the issuer. The option vests in three equal annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2020, 2021 and 2022. The performance criteria for 2020 were met, resulting in vesting of the option as to 69,444 shares.

F2 · price: On December 19, 2019, the reporting person was granted an option to purchase 208,333 shares of Class A Common Stock of the issuer. The option vests in three equal annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2020, 2021 and 2022. The performance criteria for 2020 were met, resulting in vesting of the option as to 69,444 shares.

F2 · derivative.exercise_date: On December 19, 2019, the reporting person was granted an option to purchase 208,333 shares of Class A Common Stock of the issuer. The option vests in three equal annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2020, 2021 and 2022. The performance criteria for 2020 were met, resulting in vesting of the option as to 69,444 shares.

F2 · derivative.expiration_date: On December 19, 2019, the reporting person was granted an option to purchase 208,333 shares of Class A Common Stock of the issuer. The option vests in three equal annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2020, 2021 and 2022. The performance criteria for 2020 were met, resulting in vesting of the option as to 69,444 shares.

SEC source: 0001104659-21-010444 · tm214849-7_4seq1.xml · nonDerivative · entry 1

Rietkerk Shaw · CIK 0001792695 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 305,053

F1 · balance_after: Includes 6,188 shares issued as contingent consideration pursuant to the Agreement and Plan of Merger, dated as of July 8, 2019, as amended, by and among the issuer, BM AH Holdings, LLC, Access Point Medical, Inc., DFB Merger Sub LLC, AdaptHealth Holdings LLC, Clifton Bay Offshore Investments L.P., BlueMountain Foinaven Master Fund L.P., BMSB L.P., BlueMountain Fursan Fund L.P. and AH Representative LLC.

SEC source: 0001104659-21-010439 · tm214849-6_4seq1.xml · derivative · entry 5

Parnes Josh · CIK 0001792687 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,090

Underlying: Class A Common Stock · 90,090 shares

Expires 2026-01-28

F5 · derivative.exercise_date: Options vest in three equal annual installments, beginning on January 28, 2022.

SEC source: 0001104659-21-010439 · tm214849-6_4seq1.xml · derivative · entry 4

Parnes Josh · CIK 0001792687 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,700

Underlying: Class A Common Stock · 77,700 shares

Expires 2026-01-28

F4 · derivative.exercise_date: Options vest in three equal annual installments, beginning on January 28, 2022.

SEC source: 0001104659-21-010439 · tm214849-6_4seq1.xml · derivative · entry 3

Parnes Josh · CIK 0001792687 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,600

Underlying: Class A Common Stock · 66,600 shares

Expires 2026-01-28

F3 · derivative.exercise_date: Options vest in three equal annual installments, beginning on January 28, 2022.

SEC source: 0001104659-21-010439 · tm214849-6_4seq1.xml · derivative · entry 2

Parnes Josh · CIK 0001792687 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 416,667

Underlying: Class A Common Stock · 416,667 shares

Expires not disclosed

F2 · derivative.exercise_price: On December 19, 2019, the reporting person was granted an option to purchase 1,250,000 shares of Class A Common Stock of the issuer. The option vests in three equal annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2020, 2021 and 2022. The performance criteria for 2020 were met, resulting in vesting of the option as to 416,667 shares.

F2 · price: On December 19, 2019, the reporting person was granted an option to purchase 1,250,000 shares of Class A Common Stock of the issuer. The option vests in three equal annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2020, 2021 and 2022. The performance criteria for 2020 were met, resulting in vesting of the option as to 416,667 shares.

F2 · derivative.exercise_date: On December 19, 2019, the reporting person was granted an option to purchase 1,250,000 shares of Class A Common Stock of the issuer. The option vests in three equal annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2020, 2021 and 2022. The performance criteria for 2020 were met, resulting in vesting of the option as to 416,667 shares.

F2 · derivative.expiration_date: On December 19, 2019, the reporting person was granted an option to purchase 1,250,000 shares of Class A Common Stock of the issuer. The option vests in three equal annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2020, 2021 and 2022. The performance criteria for 2020 were met, resulting in vesting of the option as to 416,667 shares.

SEC source: 0001104659-21-010425 · tm214849-2_4seq1.xml · nonDerivative · entry 1

Clemens Jason A · CIK 0001820867 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,209

SEC source: 0001104659-21-010449 · tm214849-4_4seq1.xml · derivative · entry 8

McGee Luke · CIK 0001792721 · Director · Co-Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,090

Underlying: Class A Common Stock · 90,090 shares

Expires 2026-01-28

F7 · derivative.exercise_date: Options vest in three equal annual installments, beginning on January 28, 2022

SEC source: 0001104659-21-010449 · tm214849-4_4seq1.xml · derivative · entry 7

McGee Luke · CIK 0001792721 · Director · Co-Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,700

Underlying: Class A Common Stock · 77,700 shares

Expires 2026-01-28

F6 · derivative.exercise_date: Options vest in three equal annual installments, beginning on January 28, 2022

SEC source: 0001104659-21-010449 · tm214849-4_4seq1.xml · derivative · entry 6

McGee Luke · CIK 0001792721 · Director · Co-Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,600

Underlying: Class A Common Stock · 66,600 shares

Expires 2026-01-28

F5 · derivative.exercise_date: Options vest in three equal annual installments, beginning on January 28, 2022

SEC source: 0001104659-21-010449 · tm214849-4_4seq1.xml · derivative · entry 5

McGee Luke · CIK 0001792721 · Director · Co-Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 416,667

Underlying: Class A Common Stock · 416,667 shares

Expires 2029-12-19

F4 · shares: On December 19, 2019, the reporting person was granted an option to purchase 1,250,000 shares of Class A Common Stock of the issuer. The option vests in three equal annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2020, 2021 and 2022. The performance criteria for 2020 were met, resulting in vesting of the option as to 416,667 shares.

F4 · derivative.exercise_date: On December 19, 2019, the reporting person was granted an option to purchase 1,250,000 shares of Class A Common Stock of the issuer. The option vests in three equal annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2020, 2021 and 2022. The performance criteria for 2020 were met, resulting in vesting of the option as to 416,667 shares.

SEC source: 0001104659-21-022173 · tm214849-13_4aseq1.xml · derivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Class A Common Stock · 500,000 shares

Expires 2029-12-19

F1 · shares: On December 19, 2019, the reporting person was granted an option to purchase 500,000 shares of Class A Common Stock of the issuer, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2020. The performance criteria for 2020 were met, resulting in the vesting of the option as to 500,000 shares in three equal annual installments on each of December 31, 2020, December 31, 2021 and December 31, 2022. This amendment is being filed to correct inadvertent typographical errors in the number of shares vested under the option held by the reporting person.

F1 · derivative.exercise_date: On December 19, 2019, the reporting person was granted an option to purchase 500,000 shares of Class A Common Stock of the issuer, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2020. The performance criteria for 2020 were met, resulting in the vesting of the option as to 500,000 shares in three equal annual installments on each of December 31, 2020, December 31, 2021 and December 31, 2022. This amendment is being filed to correct inadvertent typographical errors in the number of shares vested under the option held by the reporting person.

SEC source: 0001104659-21-022176 · tm214849-16_4aseq1.xml · derivative · entry 1

Rietkerk Shaw · CIK 0001792695 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 208,333

Underlying: Class A Common Stock · 208,333 shares

Expires 2029-12-19

F1 · shares: On December 19, 2019, the reporting person was granted an option to purchase 208,333 shares of Class A Common Stock of the issuer, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2020. The performance criteria for 2020 were met, resulting in the vesting of the option as to 208,333 shares in three equal annual installments on each of December 31, 2020, December 31, 2021 and December 31, 2022. This amendment is being filed to correct inadvertent typographical errors in the number of shares vested under the option held by the reporting person.

F1 · derivative.exercise_date: On December 19, 2019, the reporting person was granted an option to purchase 208,333 shares of Class A Common Stock of the issuer, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2020. The performance criteria for 2020 were met, resulting in the vesting of the option as to 208,333 shares in three equal annual installments on each of December 31, 2020, December 31, 2021 and December 31, 2022. This amendment is being filed to correct inadvertent typographical errors in the number of shares vested under the option held by the reporting person.

SEC source: 0001104659-21-022175 · tm214849-15_4aseq1.xml · derivative · entry 1

Parnes Josh · CIK 0001792687 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250,000

Underlying: Class A Common Stock · 1,250,000 shares

Expires 2029-12-19

F1 · shares: On December 19, 2019, the reporting person was granted an option to purchase 1,250,000 shares of Class A Common Stock of the issuer, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2020. The performance criteria for 2020 were met, resulting in the vesting of the option as to 1,250,000 shares in three equal annual installments on each of December 31, 2020, December 31, 2021 and December 31, 2022. This amendment is being filed to correct inadvertent typographical errors in the number of shares vested under the option held by the reporting person.

F1 · derivative.exercise_date: On December 19, 2019, the reporting person was granted an option to purchase 1,250,000 shares of Class A Common Stock of the issuer, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2020. The performance criteria for 2020 were met, resulting in the vesting of the option as to 1,250,000 shares in three equal annual installments on each of December 31, 2020, December 31, 2021 and December 31, 2022. This amendment is being filed to correct inadvertent typographical errors in the number of shares vested under the option held by the reporting person.

SEC source: 0001104659-21-022174 · tm214849-14_4aseq1.xml · derivative · entry 1

McGee Luke · CIK 0001792721 · Director · Co-Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250,000

Underlying: Class A Common Stock · 1,250,000 shares

Expires 2029-12-19

F1 · shares: On December 19, 2019, the reporting person was granted an option to purchase 1,250,000 shares of Class A Common Stock of the issuer, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2020. The performance criteria for 2020 were met, resulting in the vesting of the option as to 1,250,000 shares in three equal annual installments on each of December 31, 2020, December 31, 2021 and December 31, 2022. This amendment is being filed to correct inadvertent typographical errors in the number of shares vested under the option held by the reporting person.

F1 · derivative.exercise_date: On December 19, 2019, the reporting person was granted an option to purchase 1,250,000 shares of Class A Common Stock of the issuer, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2020. The performance criteria for 2020 were met, resulting in the vesting of the option as to 1,250,000 shares in three equal annual installments on each of December 31, 2020, December 31, 2021 and December 31, 2022. This amendment is being filed to correct inadvertent typographical errors in the number of shares vested under the option held by the reporting person.

SEC source: 0001104659-21-001157 · tm211602-1_4seq1.xml · derivative · entry 10

McGee Luke · CIK 0001792721 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Class A Common Stock · 239,793 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The Class B Common Stock was exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof).

F5 · price: The Class B Common Stock was exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof).

F5 · derivative.exercise_date: The Class B Common Stock was exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof).

F5 · derivative.expiration_date: The Class B Common Stock was exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof).

F2 · ownership.nature: Securities held directly by 2321 Capital LLC.

SEC source: 0001104659-21-001157 · tm211602-1_4seq1.xml · nonDerivative · entry 3

McGee Luke · CIK 0001792721 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 666,944

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents shares of Class A Common Stock of the Issuer issued upon an exchange of an equivalent number of shares of Class B Common Stock of the Issuer pursuant to the terms of that certain Exchange Agreement, dated as of November 8, 2019 (the "Exchange Agreement"), by and among the Issuer, AdaptHealth Holdings LLC and the other parties thereto (together with the same number of common units of AdaptHealth Holdings LLC).

F3 · ownership.nature: Securities held directly by Fresh Pond Investment LLC.

SEC source: 0001104659-21-001156 · tm211602-2_4seq1.xml · derivative · entry 2

Rietkerk Shaw · CIK 0001792695 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 89,922 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof).

F2 · price: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof).

F2 · derivative.exercise_date: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof).

F2 · derivative.expiration_date: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof).

SEC source: 0001104659-21-001156 · tm211602-2_4seq1.xml · nonDerivative · entry 1

Rietkerk Shaw · CIK 0001792695 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 290,146

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents shares of Class A Common Stock of the Issuer issued upon an exchange of an equivalent number of shares of Class B Common Stock of the Issuer pursuant to the terms of that certain Exchange Agreement, dated as of November 8, 2019, by and among the Issuer, AdaptHealth Holdings LLC and the other parties thereto (together with the same number of common units of AdaptHealth Holdings LLC).

SEC source: 0001104659-21-001157 · tm211602-1_4seq1.xml · derivative · entry 9

McGee Luke · CIK 0001792721 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Class A Common Stock · 52,384 shares

Expires not disclosed

F6 · derivative.exercise_date: The Warrants were exercisable commencing on December 8, 2019. The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation.

F6 · derivative.expiration_date: The Warrants were exercisable commencing on December 8, 2019. The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation.

F4 · ownership.nature: Securities held directly by LBM DBE Holdings LLC.

SEC source: 0001104659-21-001157 · tm211602-1_4seq1.xml · derivative · entry 8

McGee Luke · CIK 0001792721 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Class A Common Stock · 78,525 shares

Expires not disclosed

F6 · derivative.exercise_date: The Warrants were exercisable commencing on December 8, 2019. The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation.

F6 · derivative.expiration_date: The Warrants were exercisable commencing on December 8, 2019. The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation.

F3 · ownership.nature: Securities held directly by Fresh Pond Investment LLC.

SEC source: 0001104659-21-001157 · tm211602-1_4seq1.xml · derivative · entry 7

McGee Luke · CIK 0001792721 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Class A Common Stock · 93,212 shares

Expires not disclosed

F6 · derivative.exercise_date: The Warrants were exercisable commencing on December 8, 2019. The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation.

F6 · derivative.expiration_date: The Warrants were exercisable commencing on December 8, 2019. The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation.

F2 · ownership.nature: Securities held directly by 2321 Capital LLC.

SEC source: 0001104659-21-001157 · tm211602-1_4seq1.xml · derivative · entry 6

McGee Luke · CIK 0001792721 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 239,793

Underlying: Class A Common Stock · 150,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The Class B Common Stock was exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof).

F5 · price: The Class B Common Stock was exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof).

F5 · derivative.exercise_date: The Class B Common Stock was exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof).

F5 · derivative.expiration_date: The Class B Common Stock was exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof).

F2 · ownership.nature: Securities held directly by 2321 Capital LLC.

SEC source: 0001104659-21-001157 · tm211602-1_4seq1.xml · nonDerivative · entry 2

McGee Luke · CIK 0001792721 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 427,151

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents shares of Class A Common Stock of the Issuer issued upon an exchange of an equivalent number of shares of Class B Common Stock of the Issuer pursuant to the terms of that certain Exchange Agreement, dated as of November 8, 2019 (the "Exchange Agreement"), by and among the Issuer, AdaptHealth Holdings LLC and the other parties thereto (together with the same number of common units of AdaptHealth Holdings LLC).

F2 · ownership.nature: Securities held directly by 2321 Capital LLC.

SEC source: 0001104659-21-004386 · tm213263-1_4seq1.xml · nonDerivative · entry 1

Mullen Frank · CIK 0001688412 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,398

SEC source: 0000899243-20-034974 · doc4.xml · nonDerivative · entry 1

Assured Investment Management LLC · CIK 0001427430 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 0

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The filing of this Form 4 shall not be construed as an admission that Assured Investment Management LLC (f/k/a BlueMountain Capital Management, LLC) ("AssuredIM") is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any shares of Class A Common Stock, par value $0.0001 per share ("Class A Common Stock"), of AdaptHealth Corp. (the "Issuer"). Pursuant to Rule 16a-1(a)(4) of the Exchange Act, AssuredIM disclaims such beneficial ownership, except to the extent of its pecuniary interest.

F2 · security: AssuredIM is the investment manager of each of: (i) BMSB L.P. ("BMSB"); (ii) BlueMountain Fursan Fund L.P. ("FRSN"); (iii) BlueMountain Foinaven Master Fund L.P. ("BMFV"); and (iv) BlueMountain Summit Opportunities Fund II (US) L.P. Fund L.P. ( "BMSO" and, together with BMSB, FRSN and BMFV, the "Funds"), which are the direct beneficial owners of 0 shares of Class A Common Stock in the aggregate. AssuredIM, although it directs the disposition and voting of the Class A Common Stock held by the Funds, only receives an asset-based fee relating to the Class A Common Stock held by the Funds.

F3 · security: As previously reported by AssuredIM on a Form 4 filed on December 11, 2020, the Issuer delivered notice to the Funds on December 9, 2020 for the exercise of 1,898,967 call options issued by the Funds to the Issuer with respect to the Class A Common Stock of the Issuer pursuant to the terms of the Put/Call Option and Consent Agreement dated as of May 25, 2020 by and between the Issuer, the Funds and the other parties thereto.

F4 · security: On December 22, 2020, in connection with such exercise, the Funds delivered 1,898,967 shares of Class A Common Stock to the Issuer.

F3 · price: As previously reported by AssuredIM on a Form 4 filed on December 11, 2020, the Issuer delivered notice to the Funds on December 9, 2020 for the exercise of 1,898,967 call options issued by the Funds to the Issuer with respect to the Class A Common Stock of the Issuer pursuant to the terms of the Put/Call Option and Consent Agreement dated as of May 25, 2020 by and between the Issuer, the Funds and the other parties thereto.

F4 · price: On December 22, 2020, in connection with such exercise, the Funds delivered 1,898,967 shares of Class A Common Stock to the Issuer.

F1 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Assured Investment Management LLC (f/k/a BlueMountain Capital Management, LLC) ("AssuredIM") is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any shares of Class A Common Stock, par value $0.0001 per share ("Class A Common Stock"), of AdaptHealth Corp. (the "Issuer"). Pursuant to Rule 16a-1(a)(4) of the Exchange Act, AssuredIM disclaims such beneficial ownership, except to the extent of its pecuniary interest.

F2 · ownership.nature: AssuredIM is the investment manager of each of: (i) BMSB L.P. ("BMSB"); (ii) BlueMountain Fursan Fund L.P. ("FRSN"); (iii) BlueMountain Foinaven Master Fund L.P. ("BMFV"); and (iv) BlueMountain Summit Opportunities Fund II (US) L.P. Fund L.P. ( "BMSO" and, together with BMSB, FRSN and BMFV, the "Funds"), which are the direct beneficial owners of 0 shares of Class A Common Stock in the aggregate. AssuredIM, although it directs the disposition and voting of the Class A Common Stock held by the Funds, only receives an asset-based fee relating to the Class A Common Stock held by the Funds.

SEC source: 0001104659-21-020935 · tm214849-17_5seq1.xml · nonDerivative · entry 1

BARASCH RICHARD A · CIK 0001076341 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 329,920

SEC source: 0000899243-20-033905 · doc4.xml · nonDerivative · entry 1

Assured Investment Management LLC · CIK 0001427430 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Footnotes

Disclosed balance after: 1,898,967

F1 · security: The filing of this Form 4 shall not be construed as an admission that Assured Investment Management LLC (f/k/a BlueMountain Capital Management, LLC) ("AssuredIM") is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any shares of Class A Common Stock, par value $0.0001 per share ("Class A Common Stock"), of AdaptHealth Corp. (the "Issuer"). Pursuant to Rule 16a-1(a)(4) of the Exchange Act, AssuredIM disclaims such beneficial ownership, except to the extent of its pecuniary interest.

F2 · security: AssuredIM is the investment manager of each of: (i) BMSB L.P. ("BMSB"); (ii) BlueMountain Fursan Fund L.P. ("FRSN"); (iii) BlueMountain Foinaven Master Fund L.P. ("BMFV"); and (iv) BlueMountain Summit Opportunities Fund II (US) L.P. Fund L.P. ( "BMSO" and, together with BMSB, FRSN and BMFV, the "Funds"), which are the direct beneficial owners of 1,915,934 shares of Class A Common Stock in the aggregate. AssuredIM, although it directs the disposition and voting of the Class A Common Stock held by the Funds, only receives an asset-based fee relating to the Class A Common Stock held by the Funds.

F3 · security: On December 11, 2020, BMSB, FRSN, BMFV and BMSO sold 9,453, 3,765, 3,076 and 673 of Class A Common Stock, respectively, for $37.23 per share.

F1 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Assured Investment Management LLC (f/k/a BlueMountain Capital Management, LLC) ("AssuredIM") is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any shares of Class A Common Stock, par value $0.0001 per share ("Class A Common Stock"), of AdaptHealth Corp. (the "Issuer"). Pursuant to Rule 16a-1(a)(4) of the Exchange Act, AssuredIM disclaims such beneficial ownership, except to the extent of its pecuniary interest.

F2 · ownership.nature: AssuredIM is the investment manager of each of: (i) BMSB L.P. ("BMSB"); (ii) BlueMountain Fursan Fund L.P. ("FRSN"); (iii) BlueMountain Foinaven Master Fund L.P. ("BMFV"); and (iv) BlueMountain Summit Opportunities Fund II (US) L.P. Fund L.P. ( "BMSO" and, together with BMSB, FRSN and BMFV, the "Funds"), which are the direct beneficial owners of 1,915,934 shares of Class A Common Stock in the aggregate. AssuredIM, although it directs the disposition and voting of the Class A Common Stock held by the Funds, only receives an asset-based fee relating to the Class A Common Stock held by the Funds.

SEC source: 0000899243-20-033564 · doc4.xml · derivative · entry 2

Assured Investment Management LLC · CIK 0001427430 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Footnotes

Disclosed balance after: 0

Underlying: Class A and B Common Stock · 1,898,967 shares

Expires 2020-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The filing of this Form 4 shall not be construed as an admission that Assured Investment Management LLC (f/k/a BlueMountain Capital Management, LLC) ("AssuredIM") is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any put options ("Put Options") relating to shares of Class A Common Stock, par value $0.0001 per share "Class A Common Stock") and Class B Common Stock, par value $0.0001 per share ("Class B Common Stock"), of AdaptHealth Corp. (the "Issuer"). Pursuant to Rule 16a-1(a)(4) of the Exchange Act, AssuredIM disclaims such beneficial ownership, except to the extent of its pecuniary interest.

F2 · security: AssuredIM is the investment manager of each of: (i) BMSB L.P. ("BMSB"); (ii) BlueMountain Fursan Fund L.P. ("FRSN"); (iii) BlueMountain Foinaven Master Fund L.P. ("BMFV"); and (iv) BlueMountain Summit Opportunities Fund II (US) L.P. (together with BMSB, FRSN and BMFV, the "Funds"), which collectively are the direct beneficial owners of 1,898,967 Put Options. AssuredIM, although it directs the exercise of the Put Options held by the Funds, only receives an asset-based fee relating to the Put Options held by the Funds.

F3 · security: Pursuant to the Put/Call Option and Consent Agreement dated as of May 25, 2020 by and between the Issuer, the Funds and the other parties thereto (as amended, the "Option Agreement"), the Put Options may be exercised by the Funds at a per option price equal to the greater of (x) $14.50 and (y) 85% of the current market value of a share of Class A Common Stock on the date the Put Options are exercised, as determined in accordance with the terms of the Option Agreement.

F4 · security: Pursuant to the Option Agreement, both of the Put Options and the call options issued by the Funds to the Issuer with respect to the Class A Common Stock and Class B Common Stock of the Issuer (the "Call Options") will become exercisable upon the closing date of a merger involving the Issuer, certain subsidiaries thereof, Solara Holdings, LLC and certain entities related thereto.

F5 · security: Pursuant to the Option Agreement, the Put Options and Call Options each relate to the shares of Class A Common Stock and Class B Common Stock held by the Funds, without distinguishing between such shares.

F6 · security: On December 9, 2020, the Issuer delivered notice to the Funds for the exercise of 1,898,967 Call Options pursuant to the terms of the Option Agreement. In connection with such exercise, the number of Put Options held by the Funds was reduced to zero pursuant to the terms of the Option Agreement.

F4 · derivative.exercise_date: Pursuant to the Option Agreement, both of the Put Options and the call options issued by the Funds to the Issuer with respect to the Class A Common Stock and Class B Common Stock of the Issuer (the "Call Options") will become exercisable upon the closing date of a merger involving the Issuer, certain subsidiaries thereof, Solara Holdings, LLC and certain entities related thereto.

F5 · derivative.underlying: Pursuant to the Option Agreement, the Put Options and Call Options each relate to the shares of Class A Common Stock and Class B Common Stock held by the Funds, without distinguishing between such shares.

F1 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Assured Investment Management LLC (f/k/a BlueMountain Capital Management, LLC) ("AssuredIM") is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any put options ("Put Options") relating to shares of Class A Common Stock, par value $0.0001 per share "Class A Common Stock") and Class B Common Stock, par value $0.0001 per share ("Class B Common Stock"), of AdaptHealth Corp. (the "Issuer"). Pursuant to Rule 16a-1(a)(4) of the Exchange Act, AssuredIM disclaims such beneficial ownership, except to the extent of its pecuniary interest.

F2 · ownership.nature: AssuredIM is the investment manager of each of: (i) BMSB L.P. ("BMSB"); (ii) BlueMountain Fursan Fund L.P. ("FRSN"); (iii) BlueMountain Foinaven Master Fund L.P. ("BMFV"); and (iv) BlueMountain Summit Opportunities Fund II (US) L.P. (together with BMSB, FRSN and BMFV, the "Funds"), which collectively are the direct beneficial owners of 1,898,967 Put Options. AssuredIM, although it directs the exercise of the Put Options held by the Funds, only receives an asset-based fee relating to the Put Options held by the Funds.

SEC source: 0000899243-20-033564 · doc4.xml · derivative · entry 1

Assured Investment Management LLC · CIK 0001427430 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Footnotes

Disclosed balance after: 0

Underlying: Class A and B Common Stock · 1,898,967 shares

Expires 2020-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The filing of this Form 4 shall not be construed as an admission that Assured Investment Management LLC (f/k/a BlueMountain Capital Management, LLC) ("AssuredIM") is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any put options ("Put Options") relating to shares of Class A Common Stock, par value $0.0001 per share "Class A Common Stock") and Class B Common Stock, par value $0.0001 per share ("Class B Common Stock"), of AdaptHealth Corp. (the "Issuer"). Pursuant to Rule 16a-1(a)(4) of the Exchange Act, AssuredIM disclaims such beneficial ownership, except to the extent of its pecuniary interest.

F2 · security: AssuredIM is the investment manager of each of: (i) BMSB L.P. ("BMSB"); (ii) BlueMountain Fursan Fund L.P. ("FRSN"); (iii) BlueMountain Foinaven Master Fund L.P. ("BMFV"); and (iv) BlueMountain Summit Opportunities Fund II (US) L.P. (together with BMSB, FRSN and BMFV, the "Funds"), which collectively are the direct beneficial owners of 1,898,967 Put Options. AssuredIM, although it directs the exercise of the Put Options held by the Funds, only receives an asset-based fee relating to the Put Options held by the Funds.

F3 · security: Pursuant to the Put/Call Option and Consent Agreement dated as of May 25, 2020 by and between the Issuer, the Funds and the other parties thereto (as amended, the "Option Agreement"), the Put Options may be exercised by the Funds at a per option price equal to the greater of (x) $14.50 and (y) 85% of the current market value of a share of Class A Common Stock on the date the Put Options are exercised, as determined in accordance with the terms of the Option Agreement.

F4 · security: Pursuant to the Option Agreement, both of the Put Options and the call options issued by the Funds to the Issuer with respect to the Class A Common Stock and Class B Common Stock of the Issuer (the "Call Options") will become exercisable upon the closing date of a merger involving the Issuer, certain subsidiaries thereof, Solara Holdings, LLC and certain entities related thereto.

F5 · security: Pursuant to the Option Agreement, the Put Options and Call Options each relate to the shares of Class A Common Stock and Class B Common Stock held by the Funds, without distinguishing between such shares.

F6 · security: On December 9, 2020, the Issuer delivered notice to the Funds for the exercise of 1,898,967 Call Options pursuant to the terms of the Option Agreement. In connection with such exercise, the number of Put Options held by the Funds was reduced to zero pursuant to the terms of the Option Agreement.

F3 · derivative.exercise_price: Pursuant to the Put/Call Option and Consent Agreement dated as of May 25, 2020 by and between the Issuer, the Funds and the other parties thereto (as amended, the "Option Agreement"), the Put Options may be exercised by the Funds at a per option price equal to the greater of (x) $14.50 and (y) 85% of the current market value of a share of Class A Common Stock on the date the Put Options are exercised, as determined in accordance with the terms of the Option Agreement.

F4 · derivative.exercise_date: Pursuant to the Option Agreement, both of the Put Options and the call options issued by the Funds to the Issuer with respect to the Class A Common Stock and Class B Common Stock of the Issuer (the "Call Options") will become exercisable upon the closing date of a merger involving the Issuer, certain subsidiaries thereof, Solara Holdings, LLC and certain entities related thereto.

F5 · derivative.underlying: Pursuant to the Option Agreement, the Put Options and Call Options each relate to the shares of Class A Common Stock and Class B Common Stock held by the Funds, without distinguishing between such shares.

F1 · ownership.nature: The filing of this Form 4 shall not be construed as an admission that Assured Investment Management LLC (f/k/a BlueMountain Capital Management, LLC) ("AssuredIM") is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any put options ("Put Options") relating to shares of Class A Common Stock, par value $0.0001 per share "Class A Common Stock") and Class B Common Stock, par value $0.0001 per share ("Class B Common Stock"), of AdaptHealth Corp. (the "Issuer"). Pursuant to Rule 16a-1(a)(4) of the Exchange Act, AssuredIM disclaims such beneficial ownership, except to the extent of its pecuniary interest.

F2 · ownership.nature: AssuredIM is the investment manager of each of: (i) BMSB L.P. ("BMSB"); (ii) BlueMountain Fursan Fund L.P. ("FRSN"); (iii) BlueMountain Foinaven Master Fund L.P. ("BMFV"); and (iv) BlueMountain Summit Opportunities Fund II (US) L.P. (together with BMSB, FRSN and BMFV, the "Funds"), which collectively are the direct beneficial owners of 1,898,967 Put Options. AssuredIM, although it directs the exercise of the Put Options held by the Funds, only receives an asset-based fee relating to the Put Options held by the Funds.

SEC source: 0001104659-20-133873 · tm2038090-1_4seq1.xml · derivative · entry 4

JOYCE CHRISTOPHER J · CIK 0001032563 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Class A Common Stock · 266,331 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof).

F5 · price: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof).

F5 · derivative.exercise_date: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof).

F5 · derivative.expiration_date: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof).

F3 · ownership.nature: Securities held directly by Mayaid2001 LLC.

SEC source: 0001104659-20-133873 · tm2038090-1_4seq1.xml · nonDerivative · entry 2

JOYCE CHRISTOPHER J · CIK 0001032563 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 192,325

F4 · shares: Represents the number of shares of Class A Common Stock otherwise issuable upon the exchange of shares of Class B Common Stock of the Issuer (together with the same number of common units of AdaptHealth Holdings LLC) with respect to which the Issuer elected to deliver cash in lieu of shares of Class A Common Stock pursuant to the terms of the Exchange Agreement.

F3 · ownership.nature: Securities held directly by Mayaid2001 LLC.

SEC source: 0001104659-20-133873 · tm2038090-1_4seq1.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 312,325

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents shares of Class A Common Stock of the Issuer issued upon an exchange of an equivalent number of shares of Class B Common Stock of the Issuer pursuant to the terms of that certain Exchange Agreement, dated as of November 8, 2019 (the "Exchange Agreement"), by and among the Issuer, AdaptHealth Holdings LLC and the other parties thereto (together with the same number of common units of AdaptHealth Holdings LLC).

F2 · balance_after: The disposition of 24,321 shares of Class A Common Stock reported on the reporting person's Form 4 filed on December 18, 2019 was inadvertently reported as a disposition of directly held shares rather than shares held by Mayaid2001 LLC. The amounts reported as held on this Form 4 reflect the corrected number of shares directly and indirectly held.

F3 · ownership.nature: Securities held directly by Mayaid2001 LLC.

SEC source: 0001104659-20-133876 · tm2038090-3_4seq1.xml · derivative · entry 4

Rietkerk Shaw · CIK 0001792695 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,922

Underlying: Class A Common Stock · 149,871 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 119,896 of the common units of AdaptHealth Holdings LLC held by the reporting person are subject to vesting, with 29,974 units vesting on each of the first four anniversaries of May 20, 2019.

F4 · price: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 119,896 of the common units of AdaptHealth Holdings LLC held by the reporting person are subject to vesting, with 29,974 units vesting on each of the first four anniversaries of May 20, 2019.

F4 · derivative.exercise_date: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 119,896 of the common units of AdaptHealth Holdings LLC held by the reporting person are subject to vesting, with 29,974 units vesting on each of the first four anniversaries of May 20, 2019.

F4 · derivative.expiration_date: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 119,896 of the common units of AdaptHealth Holdings LLC held by the reporting person are subject to vesting, with 29,974 units vesting on each of the first four anniversaries of May 20, 2019.